Terra Nova Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $558K | Buy |
2,565
+39
| +2% | +$8.65K | 0.41% | 55 |
|
|
2025
Q4 | $577K | Buy |
2,526
+601
| +31% | +$137K | 0.38% | 57 |
|
|
2025
Q3 | $446K | Sell |
1,925
-2
| -0.1% | -$407 | 0.28% | 69 |
|
|
2025
Q2 | $358K | Buy |
1,927
+2
| +0.1% | +$372 | 0.25% | 67 |
|
|
2025
Q1 | $403K | Buy |
1,925
+2
| +0.1% | +$389 | 0.32% | 61 |
|
|
2024
Q4 | $342K | Buy |
1,923
+2
| +0.1% | +$368 | 0.26% | 69 |
|
|
2024
Q3 | $379K | Buy |
1,921
+1
| +0.1% | +$187 | 0.28% | 68 |
|
|
2024
Q2 | $329K | Buy |
1,920
+2
| +0.1% | +$331 | 0.26% | 71 |
|
|
2024
Q1 | $349K | Sell |
1,918
-63
| -3% | -$10.9K | 0.28% | 69 |
|
|
2023
Q4 | $307K | Sell |
1,981
-1,163
| -37% | -$170K | 0.27% | 67 |
|
|
2023
Q3 | $424K | Hold |
3,144
| – | – | 0.39% | 62 |
|
|
2023
Q2 | $424K | Sell |
3,144
-2,085
| -40% | -$306K | 0.39% | 62 |
|
|
2023
Q1 | $833K | Sell |
5,229
-15
| -0.3% | -$2.29K | 0.82% | 53 |
|
|
2022
Q4 | $848K | Sell |
5,244
-145
| -3% | -$22.2K | 0.89% | 48 |
|
|
2022
Q3 | $723K | Buy |
5,389
+157
| +3% | +$22.5K | 0.79% | 51 |
|
|
2022
Q2 | $801K | Buy |
5,232
+281
| +6% | +$42.9K | 0.89% | 46 |
|
|
2022
Q1 | $803K | Sell |
4,951
-32
| -0.6% | -$4.65K | 0.75% | 46 |
|
|
2021
Q4 | $675K | Buy |
4,983
+19
| +0.4% | +$2.24K | 0.51% | 54 |
|
|
2021
Q3 | $535K | Buy |
4,964
+161
| +3% | +$18.4K | 0.43% | 57 |
|
|
2021
Q2 | $541K | Sell |
4,803
-65
| -1% | -$7.32K | 0.46% | 54 |
|
|
2021
Q1 | $527K | Buy |
4,868
+18
| +0.4% | +$1.93K | 0.47% | 56 |
|
|
2020
Q4 | $520K | Buy |
+4,850
| New | +$466K | 0.52% | 48 |
|
|
2018
Q4 | $1.38M | Sell |
14,986
-914
| -6% | -$80.4K | 3.72% | 7 |
|
|
2018
Q3 | $1.5M | Sell |
15,900
-785
| -5% | -$74.4K | 2.28% | 16 |
|
|
2018
Q2 | $1.55M | Buy |
16,685
+1,316
| +9% | +$129K | 2.67% | 16 |
|
|
2018
Q1 | $1.46M | Buy |
15,369
+2,842
| +23% | +$312K | 2.58% | 11 |
|
|
2017
Q4 | $1.21M | Buy |
12,527
+7,840
| +167% | +$739K | 2.1% | 16 |
|
|
2017
Q3 | $416K | Hold |
4,687
| – | – | 0.85% | 41 |
|
|
2017
Q2 | $340K | Hold |
4,687
| – | – | 0.65% | 48 |
|
|
2017
Q1 | $305K | Sell |
4,687
-18,624
| -80% | -$1.17M | 0.61% | 47 |
|
|
2016
Q4 | $1.46M | Sell |
23,311
-1,810
| -7% | -$110K | 2.94% | 6 |
|
|
2016
Q3 | $1.58M | Sell |
25,121
-8,575
| -25% | -$555K | 3.45% | 4 |
|
|
2016
Q2 | $2.09M | Sell |
33,696
-716
| -2% | -$43.6K | 3.56% | 2 |
|
|
2016
Q1 | $1.97M | Buy |
34,412
+4,506
| +15% | +$251K | 2.3% | 5 |
|
|
2015
Q4 | $1.77M | Sell |
29,906
-22,970
| -43% | -$1.32M | 1.97% | 12 |
|
|
2015
Q3 | $2.88M | Sell |
52,876
-3,517
| -6% | -$229K | 2.55% | 4 |
|
|
2015
Q2 | $3.79M | Buy |
56,393
+4,415
| +8% | +$288K | 3.11% | 1 |
|
|
2015
Q1 | $3.04M | Buy |
+51,978
| New | +$3.14M | 2.52% | 6 |
|
Other funds holding ABBV
VCM
VPM
Terra Nova Asset Management's ABBV Position: Q1 2026 in Review
Terra Nova Asset Management increased its AbbVie (ABBV) stake by 1.5% in Q1 2026, buying an estimated $8.65K and bringing the position to 2,565 shares worth $558K. The position accounts for 0.41% of the portfolio, ranked #55.
Terra Nova Asset Management first reported a position in ABBV in Q1 2015 and has held it in 38 quarters since. The position peaked at $3.79M in Q2 2015. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Terra Nova Asset Management held 2,565 shares of AbbVie worth $558K as of Q1 2026.
- Terra Nova Asset Management bought 39 AbbVie shares in Q1 2026, an estimated $8.65K.
- AbbVie made up 0.41% of Terra Nova Asset Management's portfolio in Q1 2026, its #55 holding.
- Terra Nova Asset Management first reported a position in AbbVie in Q1 2015 and has held it in 38 quarters since.
- Terra Nova Asset Management's AbbVie position peaked at $3.79M in Q2 2015.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Terra Nova Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.